about
Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatristsAcute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systemsA case of tinnitus induced by chlorpromazine in a pediatric patient.On the relationship between human papilloma virus vaccine and autoimmune diseases.Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies.The first steps towards the era of personalised vaccinology: predicting adverse reactions.Throbbing headache associated with enoxaparin administration: a case report, a review of pharmacovigilance databases for similar cases and possible mechanisms.Antidepressants and, suicide and self-injury: Causal or casual association?A case of dysgraphia induced by sertraline and a review of official spontaneous adverse reaction databases.Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch.Neurological and psychiatric adverse events with prucalopride: case report and possible mechanisms.Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison.Sleep Disruption and Proprioceptive Delirium due to Acetaminophen in a Pediatric Patient.Late Post-traumatic Epilepsy in Children and Young Adults: Impropriety of Long-Term Antiepileptic Prophylaxis and Risks in Tapering.Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings.Levocetirizine-induced Psychiatric Disorders in a Pediatric Patient: A Case Report and a Pharmacovigilance Database Analysis.Prevention of respiratory infections in tracheostomized patients of a pediatric long-term rehabilitation setting.Kawasaki disease and pertussis epidemics.Paroxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation: Clinical Factors and Acute Pharmacological Management.On the possible interaction between vaccines and drugs.Prevalence of respiratory colonisations and related antibiotic resistances among paediatric tracheostomised patients of a long-term rehabilitation centre in Italy.Epidemiological analysis on two decades of hospitalisations for meningitis in the United States.Effect of pharmacological treatment of osteoporosis in the prevention of pathological vertebral fractures.Pharmacovigilance knowledge in family paediatricians. A survey study in Italy.Disordered Consciousness or Disordered Wakefulness? The Importance of Prolonged Polysomnography for the Diagnosis, Drug Therapy, and Rehabilitation of an Unresponsive Patient With Brain Injury.On the association between human papillomavirus vaccine and sleep disorders: Evaluation based on vaccine adverse events reporting systems.Performance of a tracheostomy removal protocol for pediatric patients in rehabilitation after acquired brain injury: Factors associated with timing and possibility of decannulation.On the association between human papillomavirus vaccine and sleep disorders: Evaluation based on vaccine adverse events reporting systems.Restless Sleep in a Hyperactive Girl: A Paradoxical Adverse Reaction to Methylphenidate.The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.Strategies empowering paediatric drug safety.Paroxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation: Pathological Features and Scheduled Pharmacological Therapies.Clinical scales for paroxysmal sympathetic hyperactivity in pediatric patients.No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase.On the Possible Relationship Between Anti-Streptolysin-O Titer and Neuropsychiatric Disorders Other than PANS.Dyskinesia caused by ziconotide-baclofen combination in an adolescent affected by cerebral palsy.Re: "Paroxysmal Sympathetic Hyperactivity: A New Era for Diagnosis and Treatment".Establishing the correlation between statins and cough: case series report and analysis of adverse drug reactions in the international databases.On the association between human papillomavirus vaccine and primary ovarian failure.Acceptance and Commitment Therapy-Oriented Parent-Training for Parents of Children with Autism
P50
Q26747123-8882E795-C85A-4536-B169-B47ECF546D5CQ28534419-A23FFA00-72C8-4481-9E99-53393621BC7EQ30438918-5B5782CA-E956-440F-BA06-6C816043DC5FQ38182260-4CD57C68-E2B1-4AE6-A4EB-5E2399BB03F4Q38226945-91E85892-F104-4401-8868-814CECB34CADQ38257150-691DB4DD-8859-4E77-9840-733E7B23D6B5Q38366295-2164F165-0416-4C77-B312-A9B62A0A96E7Q38691860-76CE2A66-02E7-4F7A-9C15-F1FC60A7072EQ38704971-AC09CFF1-73BB-4BAB-83C1-D8A9E670A96FQ39162868-E89E485C-8ED7-410A-84DC-FB9C03158447Q39223196-4A0777AB-03EE-4848-BAEE-EB68CB02D434Q39250552-2CB55B6C-C962-4370-B429-D8A930181D6AQ39504633-641ACAD1-1228-4086-B3D4-1EFFDBC5EA95Q39969835-ED3BB0B7-7FB5-4BBD-A028-9D8E797021FEQ40267262-F54C2CD1-BF16-4094-AECF-840994A9DD14Q40963068-1E91BAA0-8498-4495-A58B-44FB607DCA4AQ41489369-086153E6-179F-49E7-A15D-31D3C0409D6AQ43512067-B7911DDB-DD22-4795-943C-BF3B25A63F8CQ45131169-81926B32-8F91-4421-AA19-63A20D42B636Q45356488-6B6E1852-0240-43D7-89FB-0CE40BC5022BQ45902569-F674D0BB-1D10-4CEC-8812-44858329716EQ46049809-177E66A4-23BB-4A75-8584-07C0713BF5E9Q46079089-4703CF68-BA36-4017-AFFD-573D28E15A19Q46470487-3AC45ECF-FE56-47DD-BAF6-43F3B01005F5Q47669416-705C1251-8199-4975-94D1-672DDD36B567Q47697907-D45DFDBF-DF68-4529-88BE-352B91732EB4Q47761454-4DF59547-F1FA-4134-BABC-0043CD8C94EDQ47769852-4B545677-D647-4140-AAE4-9E566C527551Q47937610-30B1E276-C512-4BD5-8EC9-2A721722EFF4Q48107672-C9D91B78-21FD-464B-A90D-C8E8E89C4C2BQ48503839-79079717-82B0-4CF3-970C-249AF772107DQ48526013-577BC884-25FC-4A5E-93B0-B295003BF5AFQ48696179-AE76AF70-2D29-48C9-AA5A-5EBC4692513DQ49921802-A68B4A2F-B47A-437E-A391-453DE5419EDCQ50581931-437722C9-D2C6-4EF0-8134-43A0FB56DFD6Q50801645-4B1DDE27-9666-4FA8-B231-95DA4B9AF93EQ52149771-5170EEE3-1503-4261-9B6F-27DFE708B31FQ53083808-59FBB354-16A4-4F34-830C-F464898611FDQ54392128-1814E9AC-894B-4AEE-83D2-F0DD4D3E0261Q58049591-46D426DD-B541-4650-95A5-949F7D6ED754
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marco Pozzi
@ast
Marco Pozzi
@en
Marco Pozzi
@es
Marco Pozzi
@nl
type
label
Marco Pozzi
@ast
Marco Pozzi
@en
Marco Pozzi
@es
Marco Pozzi
@nl
prefLabel
Marco Pozzi
@ast
Marco Pozzi
@en
Marco Pozzi
@es
Marco Pozzi
@nl
P106
P21
P31
P496
0000-0002-3800-5697